The goal of this program is to establish the infrastructure for coordination, integration, and oversight of clinical/translational postgraduate educational and training opportunities throughout the entire Harvard University system.ĭr. Antman is the Director of the Harvard Catalyst Program for Education in Clinical and Translational Science. Antman is Director of the Skills Development Center of the Boston Biomedical Innovation Center at the Brigham and Women’s Hospital.ĭr. Clifford Barger Excellence in Mentoring Award. He is the recipient of many awards from the housestaff and has been honored for his contributions by the Harvard Medical School when it awarded him the A. Antman has been recognized for his active role and interest in education and training. His ongoing research studies help refine diagnostic and therapeutic modalities in routine clinical use today including cardiac specific troponins and novel antithrombotic agents.Īt Brigham and Women’s Hospital, Dr. The American Heart Association honored him with the 2016 Paul Dudley White Award.Īs a Senior Investigator in the TIMI Study Group, he has published on the use of serum cardiac markers for diagnosis and prognosis of patients with unstable angina and acute myocardial infarction, cyclooxygenase and cardiovascular risk, and antithrombotic therapy for acute coronary syndromes. He was President of the American Heart Association (2014-2015). Elliott Antman, MD is Professor of Medicine and Associate Dean for Clinical/Translational Research at Harvard Medical School, a Senior Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, a Senior Physician in the Cardiovascular Division of the Brigham and Women’s Hospital in Boston, Massachusetts.

Timi studio group